3. DEFINITION
“The essential feature of ADHD is
persistent pattern of inattention and /or
hyperactivity or impulsivity that is more
frequent or severe than is typically
observed in individuals at a comparable
level of development” {APA, 2000}
4. IMPULSIVENESS
trait of acting without reflection and without
thought to the consequences of the behavior .
An abrupt inclination to act ( and the inability
to resist acting ) on certain behavioral urges.
5. EPIDEMIOLOGY
Onset : Less than 4yrs
Frequency of disorder is recognized when
the child enters the school
Gender : 4 to 9 times more common in boys
than in girls
Occur as many as 3-7 % in school going
children
6. ETIOLOGY
BIOLOGICAL INFLUENCE
Genetic factors:
More in monozygotic twins than dizygotic
twins.
Siblings of hyperactive children
11. CLINICAL FEATURES
Sensitive to stimuli
Easily upset by noise, light, temperature
and other environmental changes.
Short attention span
Easily distractible
Failure to finish task
Impulsivity
Memory and thinking deficits
Specific learning disabilities.
12. CLINICAL FEATURES
In school
Restless.
Answer only the first few questions
Answer to questions before they have been completed
Unable to wait to be called on in school and may
respond before everyone else.
Has difficulty awaiting turn in games or group
situations
Often loses things necessary for tasks or activities at
school
13. CLINICAL FEATURES
In home
Explosive or irritable
Emotionally labile and easily set off to laughter or
tears
Unpredictable mood
Inability to delay gratification
Often talks excessively
Engage in physically dangerous activities .
14. DIAGNOSIS
Complete medical evaluation
A psychiatric evaluation to assess intellectual
ability, academic achievement and potential
learning disorder problem.
Detailed prenatal history
Early developmental history
Direct observation
Teachers school report, parents report.
15. MEDICAL MANAGEMENT
Central nervous system stimulants are
used for ADHD. Although these drugs are
called stimulants, they actually have a
calming effect on people with ADHD
16. MEDICAL MANAGEMENT
Dextroamphitamine { Dexadrine}
PO{ Children: 3- 5yrs } : 2.5 mg /day
6yrs or older: 5 mg / day
Pemoline {Cylert}
PO{ 6yr or more } Initial dose : 37.5 mg /day
Methylphenydate
PO{children 6yrs or older } :5- 10 mg /day .
17. MEDICAL MANAGEMENT
Atomoxetine
PO for children and adults weighing 70 kg:
Dose 40 to 80 mg daily, If weight less than
70 kg , .5mg /kg /day
20. NURSING MANAGEMENT
RISK FOR INJURY R/T IMPULSIVE AND ACCIDENT
PRONE BEHAVIOR AND INABILITY TO PERCEIVE
SELF HARM
IMPAIRED SOCIAL INTERACTION R/T INTRUSIVE
AND IMMATURE BEHAVIOR
LOW SELF ESTEEM R/T DYSFUNCTIONAL FAMILY
SYSTEM AND NEGATIVE FEED BACK
NONCOMPLIANCE WITH TASK EXPECTATIONS R/T
LOW FRUSTRATION TOLERANCE AND SHORT
ATTENTION SPAN.